Search

Parsons, H A, T Blewett, X Chu, S Sridhar, K Santos, K Xiong, V G Abramson, et al. 2023. “Circulating Tumor DNA Association With Residual Cancer Burden After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer in TBCRC 030”. Ann Oncol 34 (10): 899-906.

Baumgartner, Christina K., Hakimeh Ebrahimi-Nik, Arvin Iracheta-Vellve, Keith M. Hamel, Kira E. Olander, Thomas G. R. Davis, Kathleen A. McGuire, et al. 2023. “The PTPN2/PTPN1 Inhibitor ABBV-CLS-484 Unleashes Potent Anti-Tumour Immunity”. Nature 622 (7984): 850-62.

Dreishpoon, Margaret B, Nolan R Bick, Boryana Petrova, Douglas M Warui, Alison Cameron, Squire J Booker, Naama Kanarek, Todd R Golub, and Peter Tsvetkov. 2023. “FDX1 Regulates Cellular Protein Lipoylation through Direct Binding to LIAS”. J Biol Chem 299 (9).

Krill‑Burger, Michael, Joshua M. Dempster, Ashir A. Borah, Brenton R. Paolella, David E. Root, Todd R. Golub, Jesse S. Boehm, et al. 2023. “Partial Gene Suppression Improves Identification of Cancer Vulnerabilities When CRISPR-Cas9 Knockout Is Pan-Lethal”. Genome Biol 24 (1).

Martin, Benjamin J E, Eileen F Ablondi, Christine Goglia, Claudia A Mimoso, Piero R Espinel-Cabrera, and Karen Adelman. 2023. “Global Identification of SWI/SNF Targets Reveals Compensation by EP400.”. Cell.